Aesthetic Injectable Market Synopsis
Aesthetic Injectable Market Size Was Valued at USD 9.45 Billion in 2023, and is Projected to Reach USD 18.12 Billion by 2032, Growing at a CAGR of 7.5% from 2024-2032.
The global aesthetic injectable industry is defined as the market specializing in using injectable products to perform minimally invasive procedures that alter the physical appearance. This market is associated with a variety of treatments that are meant to address specific cosmetic issues such as the treatment of wrinkles and lines, volumetric restoration and facial shaping. Botox, which essentially contains botulinum toxin, on the other hand is administered to paralyse the underlying muscles partially for a while to produce a smooth skin and dermal fillers composed of substances including hyaluronic acid and calcium hydroxylapatite are used to fill areas lacking volume and to improve skin texture where necessary. The market is useful for facials, body shaping, skin rejuvenation and is largely implicated in hospital, specialized clinics and medical spas where professionals are expected to conduct the treatments.
- Nowadays the aesthetic injectable market constitutes an attractive and one of the most quickly developing segments of the cosmetic business being an answer to the customer demand for non-operative procedures. This market majorly consists of injectable brands like botulinum toxin and dermal fillers, which are used for different cosmetic issues like wrinkle, volume, and skin texture. Botulinum toxin is used by eliminating the contractions of the facial muscles for some time, and dermal fillers help in providing the lost volume and shape of the face. The range of these injectables is not limited to face beautification and lifting but spans body sculpting and skin rejuvenation thus being valuable to both the clinician and consumer. These commodities and services are mainly bought by hospitals, specialist clinics, and medical spas offering cosmetic procedures to their patients in safe environments consistent with patient needs and expectations.
- Regionally, the demand for the aesthetic injectable is the highest in North America given the relatively higher disposable income per capita, and the society’s embracement of aesthetic procedures. Europe is also revealing even more progress specifically because of the growing number of related clinics and the enhancement of the consumer’s awareness. Thus, the Asia-Pacific is the fastest-growing region owing to the increasing urbanization and growing beauty consciousness. However, the market is not without limitation; such include; regulatory barriers, and possible side effects of treatment. Nevertheless, it satisfies that the overall perspective of aesthetic injectable market will still has bright future because of constant development of technology and rising need for the non-surgical cosmeceuticals that improve appearance and increase self-esteem.
Aesthetic Injectable Market Trend Analysis
Notable shift towards non-invasive cosmetic treatments
- The aesthetic injectable market is shifting to a more and more non-surgical aesthetic treatment options, indicating an emerging trend of customers leaning toward the option that can bring about change without a surgery. This trend stems primarily from the need to get more comfort, save time and get satisfactory results virtually on any skin problem – from wrinkles, to volume loss, and various skin imperfections. Botulinum toxin and dermal fillers are minimally invasive procedures and, on this basis, fit the lifestyle of people who have little time for treatments and recovery. Due to the growing knowledge of these opportunities, Wellpatients are more inclined towards certain injectable procedures that may be done in a facility where they can go for a lunch break or within a break at work. The sort of access this provides is helping to normalise aesthetic treatments in a way that makes them more appealing to the masses.
- Also, the expectations of the culture in terms of aesthetics is gradually changing, especially the trend towards the appearance of come natural. People want refinement more than transformation, which is possible with non-surgical interventions that include injectables. This change is evident with a shift in the aesthetic use of injectables in combination with other dermatological procedures in order to offer a harmonized face lift solution. While certain of these products may take time to receive mastery in their application and ability to adequately address every consumer’s needs, there seems to be continually rising trend for the non-surgical cosmetic procedures. Altogether, it is a promising trend of a new era in esthetic industry, briefly called Safety First Beauty, where expectations are constituted by safety, convenience and natural results changing the cosmetic surgery landscape to the better in the future.
Rise of Male Consumers in Aesthetic Injectables
- The aesthetic injectable market is growing with a surging consumer trend among males, which is quite a change in defining male beauty. Cosmetic treatment was for many years viewed as a female domain, nevertheless transforming gender roles and expectations prompt men to turn to plastic surgeries. The increase is bridged on the following factors; awareness of one’s looks, social media, and the latest culture of grooming among men. Treatment options like botulinum toxin injections and dermal fillers are gradually moving from the periphery, as dlace focus on areas like fine lines, sagging skin, and facial volume reduction. Due to this rationale, practitioners have thus adjusted to network their services in line with the male customers. Marketing approaches are being adjusted to farther stress the utility of the aesthetic injectables targeting the male gender with emphasis in fresh, more natural appearing faces that augment idiot maxilary constructions without gender feminization.
- Furthermore, clinics and medical spas are organizing the environment in such a manner that men are willing to opt for these procedures, that are performing these treatments by male practitioners who can understand the issues. Not only does this expand existing possibilities for attracting clients for practitioners, but it is also indicates a major potentially profitable market for products, with an existing demand for formulations tailored for men’s skin. Taken in total, male consumers are an important trend in the aesthetics injectable space, which has expanded in tandem with the glorification of self-improvement and personal expression, indicating that this segment will continue to stay on course for growth in the coming years.
Aesthetic Injectable Market Segment Analysis:
Aesthetic Injectable Market is segmented on the basis of type, application and end user.
By Type, Botulinum Toxin segment is expected to dominate the market during the forecast period
- Currently, the Botulinum Toxin segment is expected to dominate the aesthetic injectable market through the forecast period due to product popularity and consumer acceptance. Botulinum toxin or most commonly associated with the brand name Botox, is used mostly to paralyze facial muscles and as a result minimize wrinkles and other signs of skin aging. It appears to be very effective because of its short treatment time, little recovery period, and significant outcome, hence the preference by people seeking cosmetic surgery procedures. The next factor is in the continual advancements in the formulations that make it look and act longer and better which has boosted sales of the product.
- The growth trend will be further strengthened by the increased number of consumers learning about botulinum toxin treatment from social media influencers and celebrities, which will make it the most preferred type of aesthetics injectable. Furthermore, the availability of clinics and medical spas providing these services can also increase treatment availability and make botulinum toxin a first choice to a number of the aesthetic population.
By Application, Facial Aesthetics segment expected to held the largest share
- Facial Aesthetics is anticipated to be the largest segment in the global aesthetic injectable market. This segment includes procedures that are aimed at beautifying features of the face, correcting such problems as aging, and smoothing out the skin on the face. Lifestyle changes that have seen individuals pay more attention on their looks, complimented by social networks displaying those beauty enhancement procedures, has caused people to look for less invasive options. Clients are willing to spend money on products and procedures that will give quick results and require little or no downtime and this has helped facial aesthetic injectables.
- Furthermore, the market for scar uses is more popular with the improved technology in techniques for scar treatment and the innovations in product development for even more natural results. While people are becoming more inclined towards seeking treatments to enhance their facial aesthetics, the global aesthetic injectables market will be a growing trend due to changes in societal culture loyalty towards beauty. This trend will continue to increase as more people opt for little to no invasive procedures to be able to look the way they want.
Aesthetic Injectable Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- The regional analysis of the aesthetic injectable market shall identify North America as the market leader within the given forecast period, owing to a better acceptance rate, high clients’ awareness about these procedures, and enhanced healthcare services. The major developed Market for such solutions are the United States and Canada, where the opportunity for the consumption of the aesthetic treatment is highly developed and has a wide range of choices for surgical and non-surgical procedures. Cosmetic procedures remain popular as consumer disposable income rises in this area and people feel comfortable paying for enhancements through procedures such as launching the botulinum toxin and dermal fillers.
- More so, through series of posts on social media and endorsements from celebrities, consumers are more likely to be convinced to swim in the aesthetic treatment bandwagon. This is particularly so given that people become more aware of how they look with regards to aging and beauty and the desire to look young is becoming a reality by the use of injectable. Moreover, the fact there are many clinics, Medical spas, and practitioners with license helps consumers find a variety of treatments that suits their situation. The availability of new product portfolios and technological in the field of injectable products can also justify higher market revenue in North America. Taken together these helps position North America as the leading market for aesthetic injectables with continued high growth rates expected through the forecast period.
Active Key Players in the Aesthetic Injectable Market
- Allergan Aesthetics (AbbVie Inc.) (USA)
- Bloomage Biotechnology Corporation Limited (China)
- Croma-Pharma GmbH (Austria)
- Daewoong Pharmaceutical Co., Ltd. (South Korea)
- Evolus, Inc. (USA)
- Hugel Inc. (South Korea)
- Ipsen S.A. (France)
- Medytox, Inc. (South Korea)
- Merz Pharma GmbH & Co. KGaA (Germany)
- Mitsubishi Tanabe Pharma Corporation (Japan)
- Revance Therapeutics, Inc. (USA)
- Shanghai Haohai Biological Technology Co., Ltd. (China)
- Sinclair Pharma (UK)
- Sino Biopharmaceutical Limited (China)
- Other Active Players
Global Aesthetic Injectable Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 9.45 Billion |
Forecast Period 2024-32 CAGR: |
7.5 % |
Market Size in 2032: |
USD 18.12 Billion |
Segments Covered: |
By Type |
|
|
By Application |
|
||
By End User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Aesthetic Injectable Market by Type
4.1 Aesthetic Injectable Market Snapshot and Growth Engine
4.2 Aesthetic Injectable Market Overview
4.3 Botulinum Toxin
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Botulinum Toxin: Geographic Segmentation Analysis
4.4 Dermal Fillers
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Dermal Fillers: Geographic Segmentation Analysis
Chapter 5: Aesthetic Injectable Market by Application
5.1 Aesthetic Injectable Market Snapshot and Growth Engine
5.2 Aesthetic Injectable Market Overview
5.3 Facial Aesthetics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Facial Aesthetics: Geographic Segmentation Analysis
5.4 Body Contouring
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Body Contouring: Geographic Segmentation Analysis
Chapter 6: Aesthetic Injectable Market by End User
6.1 Aesthetic Injectable Market Snapshot and Growth Engine
6.2 Aesthetic Injectable Market Overview
6.3 Hospitals and Clinics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals and Clinics: Geographic Segmentation Analysis
6.4 Medical Spas
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Medical Spas: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Aesthetic Injectable Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ALLERGAN AESTHETICS (USA)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 APTARGROUP INC (USA)
7.4 DYSPORT (IPSEN SA) (FRANCE)
7.5 EVOLUS INC (USA)
7.6 GALDERMA (SWITZERLAND)
7.7 HUGEL INC (SOUTH KOREA)
7.8 INMODE LTD (ISRAEL)
7.9 IPSEN SA (FRANCE)
7.10 MEDYTOX INC (SOUTH KOREA)
7.11 PROLLENIUM MEDICAL TECHNOLOGIES (CANADA)
7.12 REVANCE THERAPEUTICS INC (USA)
7.13 SIENTRA INC (USA)
7.14 TEOXANE SA (SWITZERLAND)
7.15 OTHER KEY PLAYERS
Chapter 8: Global Aesthetic Injectable Market By Region
8.1 Overview
8.2. North America Aesthetic Injectable Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Type
8.2.4.1 Botulinum Toxin
8.2.4.2 Dermal Fillers
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Facial Aesthetics
8.2.5.2 Body Contouring
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals and Clinics
8.2.6.2 Medical Spas
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Aesthetic Injectable Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Type
8.3.4.1 Botulinum Toxin
8.3.4.2 Dermal Fillers
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Facial Aesthetics
8.3.5.2 Body Contouring
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals and Clinics
8.3.6.2 Medical Spas
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Bulgaria
8.3.7.2 The Czech Republic
8.3.7.3 Hungary
8.3.7.4 Poland
8.3.7.5 Romania
8.3.7.6 Rest of Eastern Europe
8.4. Western Europe Aesthetic Injectable Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Type
8.4.4.1 Botulinum Toxin
8.4.4.2 Dermal Fillers
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Facial Aesthetics
8.4.5.2 Body Contouring
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals and Clinics
8.4.6.2 Medical Spas
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 Netherlands
8.4.7.5 Italy
8.4.7.6 Russia
8.4.7.7 Spain
8.4.7.8 Rest of Western Europe
8.5. Asia Pacific Aesthetic Injectable Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Type
8.5.4.1 Botulinum Toxin
8.5.4.2 Dermal Fillers
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Facial Aesthetics
8.5.5.2 Body Contouring
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals and Clinics
8.5.6.2 Medical Spas
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Aesthetic Injectable Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Type
8.6.4.1 Botulinum Toxin
8.6.4.2 Dermal Fillers
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Facial Aesthetics
8.6.5.2 Body Contouring
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals and Clinics
8.6.6.2 Medical Spas
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkey
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Aesthetic Injectable Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Type
8.7.4.1 Botulinum Toxin
8.7.4.2 Dermal Fillers
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Facial Aesthetics
8.7.5.2 Body Contouring
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals and Clinics
8.7.6.2 Medical Spas
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Global Aesthetic Injectable Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 9.45 Billion |
Forecast Period 2024-32 CAGR: |
7.5 % |
Market Size in 2032: |
USD 18.12 Billion |
Segments Covered: |
By Type |
|
|
By Application |
|
||
By End User |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Frequently Asked Questions :
The forecast period in the Aesthetic Injectable Market research report is 2024-2032.
Allergan Aesthetics (USA), AptarGroup, Inc. (USA), Dysport (Ipsen S.A.) (France), Evolus, Inc. (USA), Galderma (Switzerland), Hugel, Inc. (South Korea) and Other Major Players.
The Aesthetic Injectable Market is segmented into Type, Application, End User and region. By Type, the market is categorized into Botulinum Toxin, Dermal Fillers. By Application, the market is categorized into Facial Aesthetics, Body Contouring. By End User, the market is categorized into Hospitals and Clinics, Medical Spas. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
The global aesthetic injectable industry is defined as the market specializing in using injectable products to perform minimally invasive procedures that alter the physical appearance. This market is associated with a variety of treatments that are meant to address specific cosmetic issues such as the treatment of wrinkles and lines, volumetric restoration and facial shaping. Botox, which essentially contains botulinum toxin, on the other hand is administered to paralyse the underlying muscles partially for a while to produce a smooth skin and dermal fillers composed of substances including hyaluronic acid and calcium hydroxylapatite are used to fill areas lacking volume and to improve skin texture where necessary. The market is useful for facials, body shaping, skin rejuvenation and is largely implicated in hospital, specialized clinics and medical spas where professionals are expected to conduct the treatments.
Aesthetic Injectable Market Size Was Valued at USD 9.45 Billion in 2023, and is Projected to Reach USD 18.12 Billion by 2032, Growing at a CAGR of 7.5% from 2024-2032.